<bill session="118" type="h" number="7248" updated="2025-05-27T14:12:59Z">
  <state datetime="2024-02-06">REFERRED</state>
  <status>
    <introduced datetime="2024-02-06"/>
  </status>
  <introduced datetime="2024-02-06"/>
  <titles>
    <title type="display">FDA Modernization Act 3.0</title>
    <title type="short" as="introduced">FDA Modernization Act 3.0</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2024-05-10"/>
    <cosponsor bioguide_id="B001300" joined="2024-02-06"/>
    <cosponsor bioguide_id="B001257" joined="2024-02-23"/>
    <cosponsor bioguide_id="B001260" joined="2024-02-06"/>
    <cosponsor bioguide_id="B001309" joined="2024-04-19"/>
    <cosponsor bioguide_id="C000059" joined="2024-12-09"/>
    <cosponsor bioguide_id="C001126" joined="2024-06-03"/>
    <cosponsor bioguide_id="C001125" joined="2024-02-06"/>
    <cosponsor bioguide_id="C001080" joined="2024-07-22"/>
    <cosponsor bioguide_id="C001120" joined="2024-02-06"/>
    <cosponsor bioguide_id="C001121" joined="2024-08-23"/>
    <cosponsor bioguide_id="C001097" joined="2024-05-21"/>
    <cosponsor bioguide_id="D000632" joined="2024-08-23"/>
    <cosponsor bioguide_id="D000230" joined="2024-02-23"/>
    <cosponsor bioguide_id="D000216" joined="2024-02-06"/>
    <cosponsor bioguide_id="D000399" joined="2024-12-16"/>
    <cosponsor bioguide_id="F000471" joined="2024-05-01"/>
    <cosponsor bioguide_id="F000466" joined="2024-02-06"/>
    <cosponsor bioguide_id="F000462" joined="2024-07-22"/>
    <cosponsor bioguide_id="G000597" joined="2024-09-03"/>
    <cosponsor bioguide_id="G000586" joined="2024-06-05"/>
    <cosponsor bioguide_id="G000599" joined="2024-03-05"/>
    <cosponsor bioguide_id="G000589" joined="2024-02-06"/>
    <cosponsor bioguide_id="G000583" joined="2024-02-29"/>
    <cosponsor bioguide_id="H001090" joined="2024-09-10"/>
    <cosponsor bioguide_id="H001086" joined="2024-02-06"/>
    <cosponsor bioguide_id="L000599" joined="2024-03-29"/>
    <cosponsor bioguide_id="L000590" joined="2024-11-20"/>
    <cosponsor bioguide_id="L000397" joined="2024-03-21"/>
    <cosponsor bioguide_id="M000194" joined="2024-04-23"/>
    <cosponsor bioguide_id="M000317" joined="2024-12-17"/>
    <cosponsor bioguide_id="M001225" joined="2024-05-14"/>
    <cosponsor bioguide_id="N000002" joined="2024-10-25"/>
    <cosponsor bioguide_id="N000191" joined="2024-02-14"/>
    <cosponsor bioguide_id="N000026" joined="2024-02-06"/>
    <cosponsor bioguide_id="N000147" joined="2024-03-05"/>
    <cosponsor bioguide_id="O000019" joined="2024-04-05"/>
    <cosponsor bioguide_id="P000620" joined="2024-03-19"/>
    <cosponsor bioguide_id="R000305" joined="2024-03-11"/>
    <cosponsor bioguide_id="S001221" joined="2024-08-16"/>
    <cosponsor bioguide_id="S000522" joined="2024-04-19"/>
    <cosponsor bioguide_id="T000478" joined="2024-12-05"/>
    <cosponsor bioguide_id="T000468" joined="2024-03-22"/>
    <cosponsor bioguide_id="T000481" joined="2024-04-17"/>
    <cosponsor bioguide_id="V000129" joined="2024-02-13"/>
    <cosponsor bioguide_id="W000823" joined="2024-02-06"/>
  </cosponsors>
  <actions>
    <action datetime="2024-02-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2024-02-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2024-02-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="5046" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Animal protection and human-animal relationships"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Internet, web applications, social media"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2024-04-01T16:15:31Z" status="Introduced in House">FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to establish a process that supports nonclinical testing methods for drug development that do not involve the use of animals.

Specifically, the FDA must establish a pathway by which entities may apply to have nonclinical testing methods approved for use in a particular context. Qualifying methods must be intended to replace or reduce animal testing and to either improve the safety and efficacy of nonclinical testing or reduce the time to develop a drug. The FDA must issue its decision within 180 days of receiving an application. The FDA must also prioritize the review of applications for drugs that are developed using an approved nonclinical testing method.

The FDA must annually post a report on its website that summarizes the results of the bill's implementation, including the number of applications received, types of methods that were approved, and the estimated number of animals saved as result of these methods.</summary>
</bill>
